DFTX:NASDAQ
Definium Therapeutics Inc
$36.17
arrow_downward
-1.52%(-0.56) 1D
$36.58
arrow_upward
+1.12% (+0.41)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$37.00
High
$37.00
Low
$36.14
Mkt. cap
4.86B
Avg. vol.
2.11M
Volume
2.68M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$37.00
High
$37.00
Low
$36.14
Mkt. cap
4.86B
Avg. vol.
2.11M
Volume
2.68M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Investing.com Nigeria
·
7 hours ago
Form 144 DEFINIUM THERAPEUTICS For: 26 September By Investing.com
Stock Titan
·
15 hours ago
After selling 13,008 shares in June, Definium Therapeutics (DFTX) officer Mark Sullivan proposes to sell 14,051.
Stock Titan
·
16 hours ago
Two earlier share sales preceded a new proposed sale by a Definium Therapeutics (NASDAQ: DFTX) officer.
Simply Wall Street
·
1 day ago
Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com